Skip to main content
S 2622 117th Congress Senate Health Cardiovascular and respiratory health Child health Drug therapy Drug, alcohol, tobacco use Emergency medical services and trauma care Health care costs and insurance Health care coverage and access Health promotion and preventive care Infectious and parasitic diseases Medicaid Medical tests and diagnostic methods Poverty and welfare assistance Prescription drugs State and local government operations U.S. territories and protectorates

Quit Because of COVID–19 Act

Introduced: August 5, 2021 See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 5, 2021
Read twice and referred to the Committee on Finance.
Aug 5, 2021
Introduced in Senate
 Plain-English summary Congressional Research Service

Quit Because of COVID-19 Act

This bill provides for Medicaid and Children's Health Insurance Program (CHIP) coverage of certain tobacco cessation services.

Specifically, the bill provides for coverage, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines. It also applies a 100% Federal Medical Assistance Percentage (i.e., federal matching rate) for such items and services during the public health emergency relating to COVID-19 and for two years after the emergency period ends.

What's happening now August 5, 2021

Read twice and referred to the Committee on Finance.

 Committees of jurisdiction 1